Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE)

被引:38
|
作者
Bain, Kevin T. [1 ,2 ]
Schwartz, Emily J. [3 ,4 ]
Knowlton, Orsula V. [5 ]
Knowlton, Calvin H. [5 ]
Turgeon, Jacques [3 ,6 ]
机构
[1] Tabula Rasa HealthCare, Medicat Risk Mitigat, Dept Res & Dev, Moorestown, NJ USA
[2] Univ Sci, Dept Pharm, Philadelphia, PA USA
[3] Tabula Rasa HealthCare, Dept Res & Dev, Moorestown, NJ USA
[4] Univ Florida, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA
[5] Tabula Rasa HealthCare, Moorestown, NJ USA
[6] Univ Florida, Dept Pharmaceut, Gainesville, FL USA
关键词
MEDICATION THERAPY MANAGEMENT; PERSONALIZED MEDICINE; COMMUNITY PHARMACY; GENE INTERACTIONS; DRUG; PHYSICIANS; INSTRUCTION; INTEGRATION; EXPERIENCE; PROVIDERS;
D O I
10.1016/j.japh.2018.02.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To determine the feasibility of implementing a pharmacist-led pharmacogenomics (PGx) service for the Program of All-Inclusive Care for the Elderly (PACE). Setting: A national centralized pharmacy providing PGx services to community-based PACE centers. Practice description: Individuals 55 years of age and older enrolled in PACE who underwent PGx testing as part of their medical care (n = 296). Practice innovation: Pharmacist-led PGx testing, interpreting, and consulting. Evaluation: Implementation processes and roles were ascertained by reviewing policies and procedures for the PGx service and documented observations made by pharmacists providing the service. Genetic variants and drug-gene interactions (DGIs) were determined by interpretations of PGx test results. Types of recommendations provided by pharmacists were ascertained from PGx consultations. Prescribers' acceptance of recommendations were ascertained by documented responses or drug changes made after PGx consultations. Results: Challenges to implementation included lack of systems interoperability, limited access to medical electronic health records, determining prescribers' responses, and knowledge and competency gaps in PGx. Pharmacist roles most essential to overcoming challenges were interpreting and applying PGx data, determining how to disseminate those data to prescribers, advocating for appropriate PGx testing, and educating about the application of test results to clinical practice. Participants frequently used drugs posing DGI risks, with the majority (73.6%) reporting more than 1 interaction. The overwhelming majority (89.0%) of pharmacists' recommendations to mitigate risks were accepted by referring prescribers. Conclusion: Implementing a pharmacist-led PGx service for PACE is feasible. Implementation of this service highlights the leadership role of pharmacists in moving PGx from research to practice. (C) 2018 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:281 / +
页数:10
相关论文
共 50 条
  • [41] Factors that May Contribute to Low Levels of Market Penetration for PACE (Program of All-Inclusive Care for Elderly) in Kansas
    Jones, J.
    Hayley, D.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 : S227 - S228
  • [42] A quality improvement study to assess melatonin use and the impact of pharmacist desprescribing recommendations in a Progam of All-inclusive Care for the Elderly (PACE)
    Muhieddine, M.
    Lee, M.
    Lee, J.
    Zhou, C.
    Park, P.
    Bouwmeester, C. J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S246 - S246
  • [43] Program of All-Inclusive Care for the Elderly (PACE) Organizations Flip the Script in Response to the COVID-19 Pandemic
    Perry, Morgan
    McCall, Stephen
    Nardone, Michael
    Dorris, Joseph
    Obbin, Samuel
    Stanik, Christine
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2024, 25 (02) : 335 - 341.e4
  • [44] Grief and bereavement needs of PACE (program of all-inclusive care for elders) program staff.
    McCann, EM
    Somers, C
    Allen, C
    Lewis, B
    Strumpf, N
    Casarett, DJ
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S196 - S196
  • [45] ASSISTED LIVING FACILITY USE BY THE PROGRAM OF ALL-INCLUSIVE CARE FOR THE ELDERLY
    Kohli, Preeti
    Arbaje, Alicia I.
    Leff, Bruce
    Statom, Deborah
    McNabney, Matthew
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 (03) : 594 - 596
  • [46] GROWTH OF THE PROGRAM OF ALL-INCLUSIVE CARE FOR THE ELDERLY AND THE ROLE OF PRIVATE EQUITY
    Miller, Katherine
    Gupta, Ravi
    Polsky, Daniel
    INNOVATION IN AGING, 2024, 8 : 960 - 960
  • [47] Admissions and Readmissions of Patients Enrolled in a Program of All-Inclusive Care for the Elderly
    David, S.
    McNabney, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S221 - S222
  • [48] Prevalence of anticholinergic medication use in the Program of All-Inclusive Care for the Elderly
    Covington, Les
    McCarrell, Jamie
    PHARMACOTHERAPY, 2013, 33 (10): : E266 - E266
  • [49] Lessons from the end of life in the program of all-inclusive care of the elderly
    Lynn, J
    MEDICAL CARE, 2002, 40 (12) : 1133 - 1135
  • [50] Dementia, Comorbidity, and Physical Function in the Program of All-Inclusive Care for the Elderly
    Falvey, Jason R.
    Gustavson, Allison M.
    Price, Lisa
    Papazian, Lucine
    Stevens-Lapsley, Jennifer E.
    JOURNAL OF GERIATRIC PHYSICAL THERAPY, 2019, 42 (02) : E1 - E6